Norvaline2-TRH: binding to TRH receptors in rat brain homogenates

European Journal of Pharmacology

Volumn 180, Issue 1, 1990, Pages 1-12

  Vonhof, Stefan ^a   Feuerstein, Giora Z ^b   Cohen, Louis A ^a   Labroo, Virender M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

(Receptor binding); Norvaline2 TRH; TRH (thyrotropin releasing hormone); TRH analogs

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; NEUROTRANSMITTER RECEPTOR; PROTIRELIN; PROTIRELIN RECEPTOR; RECEPTORS, THYROTROPIN RELEASING HORMONE; THYROTROPIN RELEASING HORMONE, 3 ME; THYROTROPIN RELEASING HORMONE, NVAL(2); THYROTROPIN-RELEASING HORMONE, 3-ME-; THYROTROPIN-RELEASING HORMONE, NVAL(2)-; PROTIRELIN DERIVATIVE; PYROGLUTAMYLNORVALYLPROLINAMIDE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BINDING COMPETITION; BRAIN; BRAIN CORTEX; BRAIN STEM; DRUG EFFECT; FILTRATION; HYPOTHALAMUS; IN VITRO STUDY; KINETICS; MALE; METABOLISM; RAT; RAT STRAIN; ADENOHYPOPHYSIS; ANIMAL CELL; BRAIN HOMOGENATE; BRAIN REGION; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; BINDING, COMPETITIVE; BRAIN; BRAIN STEM; CEREBRAL CORTEX; FILTRATION; HYPOTHALAMUS; IN VITRO; KINETICS; MALE; PROTIRELIN; RATS; RATS, INBRED STRAINS; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, THYROTROPIN-RELEASING HORMONE; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025194620     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(90)90586-U     Document Type: Article

References (46)

1. The effects of thyrotropin-releasing hormone, metabolites and analogues on locomotor activity in rats
2. TRH-catecholamine interactions in brain and spinal cord
3. The identity of chemical and hormonal properties of the thyrotropin-releasing hormone and pyroglutamyl-histidyl-proline amide
4. Thyrotropin-releasing hormone in specific nuclei of rat brain
5. Thyrotropin-releasing hormone: Apparent receptor binding in retina
6. Thyrotropin-releasing hormone (TRH): Apparent receptor binding in rat brain membranes
7. TRH receptor binding in retina and pituitary: Major species variation
8. 50) of an enzymatic reaction
9. Modulation of pituitary thyrotropin-releasing hormone receptor levels by estrogens and thyroid hormones
10. Changes of pituitary thyrotropin-releasing hormone (TRH) receptor level and prolactin response to TRH during the rat estrous cycle
11. Biological evaluation of a TRH analogue with a modified proline residue
12. Multiple transduction mechanisms of dopamine, somatostatin and angiotensin II receptors in anterior pituitary cells
13. Thyrotropin-releasing hormone and central nervous system trauma
14. Characteristics of the pituitary binding sites for thyrotropin-releasing factor
15. GH release from avian pituitary in vitro and in vivo of TRH analogues
16. Comparative metabolism and conformation of TRH and its analogues
17. Use of TRH analogues in motor neuron disease
18. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: Possible clinical implications
19. Action of TRH and its analogues on the mesolimbic dopamine system
20. Effects of TRH and TRH analogues on the central regulation of breathing in the rat
21. Receptor binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolacting-producing pituitary cells in culture
22. Thyrotropin-releasing hormone: Neurogenesis of actions in the pentobarbital narcotized rat
23. 2-TRH
24. The use of analogues of TRH to probe the specificity of pyroglutamyl peptidase II
25. Pro-TRH gene expresion and precursor peptides in rat brain. Observations by hybridization analysis and immunocytochemistry
26. Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistance to metabolic degradation
27. neuropharmacological evaluation of RX 77368 — a stabilized analogue of thyrotropin-releasing hormone (TRH)
28. Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability
29. γ-Butyrolactone-γ-carbonyl-histidyl-prolinamide citrate (DN-1417): A novel TRH analog with potent effects on the central nervous system
30. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
31. Synthesis of thyrotropin-releasing hormone analogues with selective central nervous system effects
32. TRH analog administration increases endogenous TRH levels in the central nervous system
33. Effects of MK-771, a novel TRH analog, on brain dopaminergic and serotoninergic systems
34. Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity
35. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus
36. Quantitative autoradiography of TRH receptors in discrete brain regions of different mammalian species
37. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat
38. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat
39. Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity
40. 2)-TRH binding to apparent TRH receptors in the sheep central nervous system
41. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro
42. 2-TRH: Binding to thyrotropin-releasing hormone (TRH) receptors in the rat brain
43. Receptor binding of fluorinated histidine analogs of thyrotropin-releasing hormone in various regions of the rat brain
44. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotropin-releasing hormone (TRH)
45. Thyrotropin-releasing hormone: Regional distribution in rat brain
46. Studies on the neuropharmacology of thyrotropin-releasing hormone (TRH) and a new TRH analog